Closing in on accurate risk prediction and disease management for patients with operable GIST

Affiliations

Comment

Anette Duensing. Lancet Oncol. 2012 Mar.

. 2012 Mar;13(3):220-1.

doi: 10.1016/S1470-2045(11)70344-8. Epub 2011 Dec 6.

¹ University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. aduensin@pitt.edu

No abstract available

Comment on

Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
Joensuu H, Vehtari A, Riihimäki J, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson MK, Linke Z, Sufliarsky J, Federico M, Jonasson JG, Dei Tos AP, Rutkowski P. Joensuu H, et al. Lancet Oncol. 2012 Mar;13(3):265-74. doi: 10.1016/S1470-2045(11)70299-6. Epub 2011 Dec 6. Lancet Oncol. 2012. PMID: 22153892 Review.